Yue‐Bei Luo

1.3k total citations
52 papers, 906 citations indexed

About

Yue‐Bei Luo is a scholar working on Molecular Biology, Neurology and Epidemiology. According to data from OpenAlex, Yue‐Bei Luo has authored 52 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Neurology and 13 papers in Epidemiology. Recurrent topics in Yue‐Bei Luo's work include Inflammatory Myopathies and Dermatomyositis (11 papers), Muscle Physiology and Disorders (9 papers) and Nuclear Structure and Function (8 papers). Yue‐Bei Luo is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (11 papers), Muscle Physiology and Disorders (9 papers) and Nuclear Structure and Function (8 papers). Yue‐Bei Luo collaborates with scholars based in China, Australia and United States. Yue‐Bei Luo's co-authors include Frank Mastaglia, Huan Yang, Kun Huang, Qiuming Zeng, Huan Yang, Steve D. Wilton, Chuanzhu Yan, Yuying Zhao, Victoria A. Fabian and Fangfang Bi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Yue‐Bei Luo

51 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yue‐Bei Luo China 18 403 275 191 162 126 52 906
Mingzhe Zheng China 19 497 1.2× 254 0.9× 171 0.9× 287 1.8× 41 0.3× 43 1.1k
Irene Bottillo Italy 18 531 1.3× 110 0.4× 98 0.5× 257 1.6× 114 0.9× 65 1.1k
Víctor Martínez‐Glez Spain 22 603 1.5× 231 0.8× 54 0.3× 161 1.0× 309 2.5× 61 1.4k
Salma M. Wakil Saudi Arabia 19 517 1.3× 293 1.1× 154 0.8× 45 0.3× 47 0.4× 67 1.2k
Robert W. A. M. Kuijpers Netherlands 22 369 0.9× 324 1.2× 211 1.1× 64 0.4× 74 0.6× 64 1.7k
Kentaro Ohara Japan 16 170 0.4× 166 0.6× 102 0.5× 114 0.7× 57 0.5× 54 636
Robin Buerki United States 11 225 0.6× 286 1.0× 99 0.5× 255 1.6× 35 0.3× 25 754
Heiko Pfister Germany 9 209 0.5× 112 0.4× 195 1.0× 167 1.0× 80 0.6× 14 773
Kashish Chetal United States 17 787 2.0× 89 0.3× 300 1.6× 46 0.3× 90 0.7× 33 1.3k
Yamei Gao United States 9 327 0.8× 176 0.6× 112 0.6× 66 0.4× 61 0.5× 9 1.0k

Countries citing papers authored by Yue‐Bei Luo

Since Specialization
Citations

This map shows the geographic impact of Yue‐Bei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue‐Bei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue‐Bei Luo more than expected).

Fields of papers citing papers by Yue‐Bei Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue‐Bei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue‐Bei Luo. The network helps show where Yue‐Bei Luo may publish in the future.

Co-authorship network of co-authors of Yue‐Bei Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yue‐Bei Luo. A scholar is included among the top collaborators of Yue‐Bei Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue‐Bei Luo. Yue‐Bei Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huang, Kun, et al.. (2022). CASQ1 ‐related myopathy: The first report from China and the literature review. SHILAP Revista de lepidopterología. 10(12). e6689–e6689. 4 indexed citations
3.
Huang, Kun, et al.. (2022). Expanding the clinicopathological-genetic spectrum of glycogen storage disease type IXd by a Chinese neuromuscular center. Frontiers in Neurology. 13. 945280–945280. 4 indexed citations
4.
Huang, Kun, et al.. (2022). Findings of limb-girdle muscular dystrophy R7 telethonin-related patients from a Chinese neuromuscular center. Neurogenetics. 23(1). 37–44. 6 indexed citations
5.
Luo, Yue‐Bei, et al.. (2021). Expanding the clinicopathological‐genetic spectrum of GNE myopathy by a Chinese neuromuscular centre. Journal of Cellular and Molecular Medicine. 25(22). 10494–10503. 12 indexed citations
6.
Lin, Yan, Dandan Zhao, Fuchen Liu, et al.. (2020). A novel m.11406 T > A mutation in mitochondrial ND4 gene causes MELAS syndrome. Mitochondrion. 54. 57–64. 4 indexed citations
7.
Zhou, Ran, Yue‐Bei Luo, Qiuming Zeng, & Huan Yang. (2020). Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases. Frontiers in Immunology. 11. 1884–1884. 46 indexed citations
8.
Li, Qiuxiang, et al.. (2020). The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies. Clinical Rheumatology. 40(2). 613–624. 7 indexed citations
9.
Zhang, Wei, Bing Wen, Jun Lü, et al.. (2019). Neutral lipid storage disease with myopathy in China: a large multicentric cohort study. Orphanet Journal of Rare Diseases. 14(1). 234–234. 19 indexed citations
10.
Hou, Ying, Meirong Liu, Yue‐Bei Luo, et al.. (2018). Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort. Neuromuscular Disorders. 29(1). 5–13. 28 indexed citations
11.
Meng, Huanyu, Liqun Xu, Yi Li, et al.. (2017). IFNA-AS1 regulates CD4+ T cell activation in myasthenia gravis though HLA-DRB1. Clinical Immunology. 183. 121–131. 37 indexed citations
12.
Zeng, Qiuming, Xiaohua Dong, Bo Hu, et al.. (2016). CD14+CD16++ monocytes are increased in patients with NMO and are selectively suppressed by glucocorticoids therapy. Journal of Neuroimmunology. 300. 1–8. 17 indexed citations
13.
Xu, Jingwen, Fuchen Liu, Wěi Li, et al.. (2016). Cylindrical Spirals in Skeletal Muscles Originate From the Longitudinal Sarcoplasmic Reticulum. Journal of Neuropathology & Experimental Neurology. 75(2). 148–155. 4 indexed citations
14.
Ji, Kunqian, Jingwei Lv, Jingwen Xu, et al.. (2015). Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR–YY1–PGC1α pathway. Free Radical Biology and Medicine. 84. 161–170. 70 indexed citations
15.
Luo, Zhaohui, Ye Li, Xiaofang Liu, et al.. (2015). Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes. BMC Medical Genomics. 8(1). 13–13. 30 indexed citations
16.
Luo, Yue‐Bei & Frank Mastaglia. (2014). Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(4). 622–632. 54 indexed citations
17.
Shan, Jingli, Bin Chen, Pengfei Lin, et al.. (2014). Oculopharyngeal Muscular Dystrophy: Phenotypic and Genotypic Studies in a Chinese Population. NeuroMolecular Medicine. 16(4). 782–786. 12 indexed citations
18.
Ji, Kunqian, Kaiming Liu, Pengfei Lin, et al.. (2013). Twinkle mutations in two Chinese families with autosomal dominant progressive external ophthalmoplegia. Neurological Sciences. 35(3). 443–448. 3 indexed citations
19.
Ji, Kunqian, Fuchen Liu, Jingli Shan, et al.. (2013). Novel Mitochondrial C15620A Variant may Modulate the Phenotype of Mitochondrial G11778A Mutation in a Chinese Family with Leigh Syndrome. NeuroMolecular Medicine. 16(1). 119–126. 8 indexed citations
20.
Jiang, Hong, et al.. (2010). [Analysis of mtDNA 12SrRNA A1555G mutations of Uigur patients with nonsyndromic hereditary hearing loss in Xinjiang].. PubMed. 24(10). 439–41, 446. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingzhe Zheng Breakdown of academic impact, for papers by Irene Bottillo Breakdown of academic impact, for papers by Víctor Martínez‐Glez Breakdown of academic impact, for papers by Salma M. Wakil Breakdown of academic impact, for papers by Robert W. A. M. Kuijpers Breakdown of academic impact, for papers by Kentaro Ohara Breakdown of academic impact, for papers by Robin Buerki Breakdown of academic impact, for papers by Heiko Pfister Breakdown of academic impact, for papers by Kashish Chetal Breakdown of academic impact, for papers by Yamei Gao
Rankless by CCL
2026